
<p>Reuters <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/catalents-indiana-plant-make-novos-wegovy-weight-loss-drug-sources-2023-08-25/"><strong>exclusively reported</strong></a> that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but the identity of the company has not previously been reported. This was followed by another exclusive that Catalent&#8217;s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk&#8217;s  Wegovy as part of the two companies&#8217; expanded supply agreement. Catalent’s shares briefly jumped on the news. </p>
<p>The post <a rel="nofollow" href="https://www.reutersagency.com/en/reutersbest/article/catalents-indiana-plant-to-make-novos-wegovy-weight-loss-drug/">Catalent&#8217;s Indiana plant to make Novo&#8217;s Wegovy weight-loss drug </a> appeared first on <a rel="nofollow" href="https://www.reutersagency.com/en/">Reuters News Agency</a>.</p>
